Format

Send to

Choose Destination
Arthritis Rheum. 2004 Aug;50(8):2415-22.

Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus.

Author information

1
Center for Drug Evaluation and Research, FDA, Rockville, Maryland 20850, USA. schiffenbaue@cder.fda.gov
PMID:
15334452
DOI:
10.1002/art.20353
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center